The effects of analgesics on central processing of tonic pain: A cross-over placebo controlled study. (1st September 2017)
- Record Type:
- Journal Article
- Title:
- The effects of analgesics on central processing of tonic pain: A cross-over placebo controlled study. (1st September 2017)
- Main Title:
- The effects of analgesics on central processing of tonic pain: A cross-over placebo controlled study
- Authors:
- Lelic, Dina
Hansen, Tine M.
Mark, Esben B.
Olesen, Anne E.
Drewes, Asbjørn M. - Abstract:
- Abstract: Introduction: Opioids and antidepressants that inhibit serotonin and norepinephrine reuptake (SNRI) are recognized as analgesics to treat moderate to severe pain, but the central mechanisms underlying their analgesia remain unclear. This study investigated how brain activity at rest and exposed to tonic pain is modified by oxycodone (opioid) and venlafaxine (SNRI). Methods: Twenty healthy males were included in this randomized, cross-over, double-blinded study. 61-channel electroencephalogram (EEG) was recorded before and after five days of treatment with placebo, oxycodone (10 mg extended release b.i.d) or venlafaxine (37.5 mg extended release b.i.d) at rest and during tonic pain (hand immersed in 2 °C water for 80 s). Subjective pain and unpleasantness scores of tonic pain were recorded. Spectral analysis and sLORETA source localization were done in delta (1–4 Hz), theta (4–8 Hz), alpha (8–12 Hz), beta1 (12–18 Hz) and beta2 (18–32 Hz) frequency bands. Results: Oxycodone decreased pain and unpleasantness scores ( P < 0.05), whereas venlafaxine decreased the pain scores ( P < 0.05). None of the treatments changed the spectral indices or brain sources underlying resting EEG. Venlafaxine decreased spectral indices in alpha band of the EEG to tonic pain, whereas oxycodone decreased the spectral indices and brain source activity in delta and theta frequency bands (all P < 0.05). The brain source activity predominantly decreased in the insula and inferior frontalAbstract: Introduction: Opioids and antidepressants that inhibit serotonin and norepinephrine reuptake (SNRI) are recognized as analgesics to treat moderate to severe pain, but the central mechanisms underlying their analgesia remain unclear. This study investigated how brain activity at rest and exposed to tonic pain is modified by oxycodone (opioid) and venlafaxine (SNRI). Methods: Twenty healthy males were included in this randomized, cross-over, double-blinded study. 61-channel electroencephalogram (EEG) was recorded before and after five days of treatment with placebo, oxycodone (10 mg extended release b.i.d) or venlafaxine (37.5 mg extended release b.i.d) at rest and during tonic pain (hand immersed in 2 °C water for 80 s). Subjective pain and unpleasantness scores of tonic pain were recorded. Spectral analysis and sLORETA source localization were done in delta (1–4 Hz), theta (4–8 Hz), alpha (8–12 Hz), beta1 (12–18 Hz) and beta2 (18–32 Hz) frequency bands. Results: Oxycodone decreased pain and unpleasantness scores ( P < 0.05), whereas venlafaxine decreased the pain scores ( P < 0.05). None of the treatments changed the spectral indices or brain sources underlying resting EEG. Venlafaxine decreased spectral indices in alpha band of the EEG to tonic pain, whereas oxycodone decreased the spectral indices and brain source activity in delta and theta frequency bands (all P < 0.05). The brain source activity predominantly decreased in the insula and inferior frontal gyrus. Conclusion: The decrease of activity within insula and inferior frontal gyrus is likely involved in pain inhibition due to oxycodone treatment, whereas the decrease in alpha activity is likely involved in pain inhibition due to venlafaxine treatment. Highlights: Oxycodone decreased delta and theta spectral indices of EEG to tonic pain. Oxycodone decreased the brain activity underlying delta and theta EEG bands. Venlafaxine decreased alpha spectral indices of EEG to tonic pain. Brain activity underlying lower EEG frequencies is likely important in opioid analgesia. Alpha EEG activity is likely important in SNRI analgesia. … (more)
- Is Part Of:
- Neuropharmacology. Volume 123(2017)
- Journal:
- Neuropharmacology
- Issue:
- Volume 123(2017)
- Issue Display:
- Volume 123, Issue 2017 (2017)
- Year:
- 2017
- Volume:
- 123
- Issue:
- 2017
- Issue Sort Value:
- 2017-0123-2017-0000
- Page Start:
- 455
- Page End:
- 464
- Publication Date:
- 2017-09-01
- Subjects:
- SNRI -- Opioid -- EEG -- Brain source localization -- LORETA
Neuropsychopharmacology -- Periodicals
Autonomic Agents -- Periodicals
Neuropsychopharmacologie -- Périodiques
Neuropsychopharmacology
Periodicals
Electronic journals
615.78 - Journal URLs:
- http://www.sciencedirect.com/science/journal/00283908 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.neuropharm.2017.06.022 ↗
- Languages:
- English
- ISSNs:
- 0028-3908
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6081.517500
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 2846.xml